Livestock Parasiticides Market By Type  (Ectoparasiticides , Endoparasiticides , Endectocides), By Livestock (Cattle, Pigs, Poultry, Sheep and goats), By End user (Veterinary clinics and hospitals, Animal farms): Global Opportunity Analysis and Industry Forecast, 2021-2031

Livestock Parasiticides Market

The livestock parasiticides market is meant to provide the chemical substances that remove parasites other than fungi and bacteria in animal livestock. These chemicals are generally inert ingredients that are made in a formulation comprising of one or more than one active ingredients.

Most of the parasiticidal have active ingredients, which have similar chemical structures and have many of the common features among them. They are grouped into different chemical classes and families as well. Many key players and companies throughout the world are coming up with various new formulations and products in the livestock parasiticides market to remove the increasing prevalence of diseases among livestock. The major factors that drive the Livestock Parasiticides Market Growth are increasing regulations for preventing the spread of animal diseases as animal diseases pose threat to public health and cause damage to businesses and the economy at large.

Farmers and the government take every precaution to prevent these diseases by taking measures such as keeping animal housing clean and vaccinating livestock. The governments of various countries across the globe monitors animal health in association with a different organizations such as consumer products safety authorities, which helps them to take immediate action in the event of an outbreak of infectious disease among livestock animal, they also help in identifying the causes of animal diseases that do not normally occur in a particular region.

Thus, such initiatives by the government also help in spreading awareness among livestock farm owners and also help in joint venture programs between key players and farm owners to R&D and develop effective livestock health products thus driving the market demand. Climate seasonality and weather events such as pressure humidity, wind speed, and the direct influence of zoonotic spread. Climate change has increased the range and the number of viruses and bacteria to which animals may be exposed as well as competent vectors and the receiver species. Livestock parasiticides provide benefits for the treatment of zoonotic diseases. They can be used by veterinary physicians and hospital staff. The key players are offering livestock parasiticides and are developing value-added features such as effective sprays, dips, and collars. These rising concerns about zoonotic diseases due to the increasing number of livestock farms and the rise in demand for meat across the globe have led to Livestock Parasiticides Market Share.

Furthermore, the outbreak of the COVID-19 pandemic had a mixed impact on livestock Parasiticides Market Trends. There was a significant decline in the demand for animal health products. Some of the leading players in the animal health business around the world witnessed a decline, which is attributed to a decrease demand for animal business primarily in clinical administrator pharmaceuticals where social distancing guidelines led to a decrease in veterinary visits. However, the rising concern about pet health and the increasing adoption of pets during the pandemic ultimately led to an increase in Livestock Parasiticides Market Demand. , also, the increasing demand for home healthcare making a positive impact to the market.

The livestock parasiticides market is expected to witness significant growth, owing to a surge in demand for protein food or animal-derived food and an increase in the incidence of zoonotic and food-borne diseases globally. In addition, the increasing investments by the private players, regulations for preventing the spread of animal diseases, and rising animal health expenditures are the key drivers of the market.

The growth in demand in the livestock parasiticides market for effective drugs is the key attraction for the leading market players with huge investments in the industry. Moreover, it is one of the major drivers boosting R&D efforts in the animal health industry. At present many leading market players are focusing on R&D to develop new drugs. It was also found that globally the spending on R&D in animal healthcare is about 7 to 8% of the total revenue of individual market players. And according to the European international federation of animal health, it was found that the major players are spending about 12% of their annual sales on R&D activities. On the other hand, 6% of annual sales are invested on R&D activities by the small and medium players.

Some of the key players in the livestock parasiticides industry include Elanco animal health Incorporated, Boehringer Ingelheim Gmbh, Zoetis Inc. Merck & Co.Inc, virbac, Vetoquinol S.A., Petiq, Llc, Sequent Scientific Limited, Krka Group, Eco Animal Health Group Plc, Ceva Santé Animale, Chanelle Pharm, Bimeda Animal Health and Norbrook.

Key findings of the study

By type, the livestock parasiticides, and ectoparasiticides segment dominated the global market in 2021, and is expected to retain its dominance throughout the market forecast period.

On the basis of livestock, the cattle segment accounted for a major share in the livestock parasiticides market in 2021, and is expected to grow at a significant CAGR during the forecast period.

Depending on end user, the veterinary clinics and hospitals segment accounted for a major share of the market in 2021, and is expected to grow at a significant CAGR during the forecast period.

Asia-Pacific accounted for highest market share in 2021, and is expected to grow at a significant CAGR during the forecast period.

Overview

The livestock parasiticides market size was valued at $2,607.4 million in 2021, and is projected to reach $4,855 million by 2031, registering a CAGR of 6.7% from 2022 to 2031. The livestock parasiticides market is meant to provide the chemical substances that remove parasites other than fungi and bacteria in livestock. These chemicals are generally inert ingredients that are made in a formulation and consist of one or more than one active ingredient in it. Most of the parasiticidal have active ingredients, which have similar chemical structures and have many of the common features among them. They are grouped into different chemical classes and families as well. The importance of the livestock parasiticides has been recognized for the protection and the cure of parasitic diseases in the animal. Many key players and the companies throughout the world are coming up with various new formulations and the products in the livestock parasiticides market to remove the increasing prevalence of the foodborne diseases.

The major factors that drive the growth of the livestock parasiticides market are increasing awareness about animal healthcare worldwide. Moreover, the escalating number of livestock animals for the purpose of food production in the emerging economies is leading to rising demand for animal healthcare products. And surge in the animal healthcare expenditure for animal welfare to improve their health of livestock animals further fuels the overall livestock parasiticides market.It was also found that there was mixed impact of COVID-19 on livestock parasiticides market.

There was significant decline in the demand for animal health products. The decline in demand for livestock business primarily in clinical administrator pharmaceuticals segment was due to social distancing guidelines followed across the globe led to decrease in veterinary clinical visit.. However, the rising concern about the livestock health during the pandemic ultimately led to increase in market demand.

The market in North America dominates the global livestock parasiticides market due to its well-established base of animal health industry along with rise in expenditure on animal healthcare. Whereas Asia-Pacific is expected to grow at a faster CAGR of 7.7% from 2022 to 2031, due to the presence of some of the largest animal farms such as pigs and the poultry farms in the countries such as China and India and this ultimately results in the substantial growth of the market in the region. The market in Latin America is expected to grow in upcoming future due to rise in population of livestock animals and increase in consumption of animal derived food products in the region.

A growth in preference for vegetarian food & diet coupled with the restrictions and the long approval process for livestock parasiticides for livestock animals are some of the restraints affecting the global livestock parasiticides market. The livestock parasiticides market is segmented into type, livestock, end user, and region. On the basis of type, the market is fragmented into ectoparasiticides, endoparasiticides , and endectocides. On the basis of livestock, the market is categorized into cattle, pigs, poultry, sheep, and goats. On the basis of end user, the market is bifurcated into veterinary clinics & hospitals and animal farms. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, The Netherlands , Switzerland and rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Thailand, and rest of Asia-Pacific), and LAMEA (Latin America, Middle East, & Africa).

Key Benefits For Stakeholders

●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the livestock parasiticides market analysis from 2021 to 2031 to identify the prevailing livestock parasiticides market opportunities.

●The market research is offered along with information related to key drivers, restraints, and opportunities.

●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

●In-depth analysis of the livestock parasiticides market segmentation assists to determine the prevailing market opportunities.

●Major countries in each region are mapped according to their revenue contribution to the global market.

●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

●The report includes the analysis of the regional as well as global livestock parasiticides market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

○ Kyoritsuseiyak

Scope of Livestock Parasiticides Market Report

1.1.Report description

1.2.Key market segments

1.3.Key benefits to the stakeholders

1.4.Research Methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

2.1.Key findings of the study

2.2.CXO Perspective

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.4.Top player positioning

3.5.Market dynamics

3.5.1.Drivers

3.5.2.Restraints

3.5.3.Opportunities

3.6.COVID-19 Impact Analysis on the market

4.1 Overview

4.1.1 Market size and forecast

4.2 Ectoparasiticides

4.2.1 Key market trends, growth factors and opportunities

4.2.2 Market size and forecast, by region

4.2.3 Market analysis by country

4.3 Endoparasiticides

4.3.1 Key market trends, growth factors and opportunities

4.3.2 Market size and forecast, by region

4.3.3 Market analysis by country

4.4 Endectocides

4.4.1 Key market trends, growth factors and opportunities

4.4.2 Market size and forecast, by region

4.4.3 Market analysis by country

5.1 Overview

5.1.1 Market size and forecast

5.2 Cattle

5.2.1 Key market trends, growth factors and opportunities

5.2.2 Market size and forecast, by region

5.2.3 Market analysis by country

5.3 Pigs

5.3.1 Key market trends, growth factors and opportunities

5.3.2 Market size and forecast, by region

5.3.3 Market analysis by country

5.4 Poultry

5.4.1 Key market trends, growth factors and opportunities

5.4.2 Market size and forecast, by region

5.4.3 Market analysis by country

5.5 Sheep and goats

5.5.1 Key market trends, growth factors and opportunities

5.5.2 Market size and forecast, by region

5.5.3 Market analysis by country

6.1 Overview

6.1.1 Market size and forecast

6.2 Veterinary clinics and hospitals

6.2.1 Key market trends, growth factors and opportunities

6.2.2 Market size and forecast, by region

6.2.3 Market analysis by country

6.3 Animal farms

6.3.1 Key market trends, growth factors and opportunities

6.3.2 Market size and forecast, by region

6.3.3 Market analysis by country

7.1 Overview

7.1.1 Market size and forecast

7.2 North America

7.2.1 Key trends and opportunities

7.2.2 North America Market size and forecast, by Type

7.2.3 North America Market size and forecast, by Livestock

7.2.4 North America Market size and forecast, by End user

7.2.5 North America Market size and forecast, by country

7.2.5.1 U.S.

7.2.5.1.1 Market size and forecast, by Type

7.2.5.1.2 Market size and forecast, by Livestock

7.2.5.1.3 Market size and forecast, by End user

7.2.5.2 Canada

7.2.5.2.1 Market size and forecast, by Type

7.2.5.2.2 Market size and forecast, by Livestock

7.2.5.2.3 Market size and forecast, by End user

7.2.5.3 Mexico

7.2.5.3.1 Market size and forecast, by Type

7.2.5.3.2 Market size and forecast, by Livestock

7.2.5.3.3 Market size and forecast, by End user

7.3 Europe

7.3.1 Key trends and opportunities

7.3.2 Europe Market size and forecast, by Type

7.3.3 Europe Market size and forecast, by Livestock

7.3.4 Europe Market size and forecast, by End user

7.3.5 Europe Market size and forecast, by country

7.3.5.1 UK

7.3.5.1.1 Market size and forecast, by Type

7.3.5.1.2 Market size and forecast, by Livestock

7.3.5.1.3 Market size and forecast, by End user

7.3.5.2 Italy

7.3.5.2.1 Market size and forecast, by Type

7.3.5.2.2 Market size and forecast, by Livestock

7.3.5.2.3 Market size and forecast, by End user

7.3.5.3 Germany

7.3.5.3.1 Market size and forecast, by Type

7.3.5.3.2 Market size and forecast, by Livestock

7.3.5.3.3 Market size and forecast, by End user

7.3.5.4 France

7.3.5.4.1 Market size and forecast, by Type

7.3.5.4.2 Market size and forecast, by Livestock

7.3.5.4.3 Market size and forecast, by End user

7.3.5.5 Spain

7.3.5.5.1 Market size and forecast, by Type

7.3.5.5.2 Market size and forecast, by Livestock

7.3.5.5.3 Market size and forecast, by End user

7.3.5.6 The Netherlands

7.3.5.6.1 Market size and forecast, by Type

7.3.5.6.2 Market size and forecast, by Livestock

7.3.5.6.3 Market size and forecast, by End user

7.3.5.7 Switzerland

7.3.5.7.1 Market size and forecast, by Type

7.3.5.7.2 Market size and forecast, by Livestock

7.3.5.7.3 Market size and forecast, by End user

7.3.5.8 Rest of Europe

7.3.5.8.1 Market size and forecast, by Type

7.3.5.8.2 Market size and forecast, by Livestock

7.3.5.8.3 Market size and forecast, by End user

7.4 Asia-Pacific

7.4.1 Key trends and opportunities

7.4.2 Asia-Pacific Market size and forecast, by Type

7.4.3 Asia-Pacific Market size and forecast, by Livestock

7.4.4 Asia-Pacific Market size and forecast, by End user

7.4.5 Asia-Pacific Market size and forecast, by country

7.4.5.1 China

7.4.5.1.1 Market size and forecast, by Type

7.4.5.1.2 Market size and forecast, by Livestock

7.4.5.1.3 Market size and forecast, by End user

7.4.5.2 Japan

7.4.5.2.1 Market size and forecast, by Type

7.4.5.2.2 Market size and forecast, by Livestock

7.4.5.2.3 Market size and forecast, by End user

7.4.5.3 India

7.4.5.3.1 Market size and forecast, by Type

7.4.5.3.2 Market size and forecast, by Livestock

7.4.5.3.3 Market size and forecast, by End user

7.4.5.4 South Korea

7.4.5.4.1 Market size and forecast, by Type

7.4.5.4.2 Market size and forecast, by Livestock

7.4.5.4.3 Market size and forecast, by End user

7.4.5.5 Australia

7.4.5.5.1 Market size and forecast, by Type

7.4.5.5.2 Market size and forecast, by Livestock

7.4.5.5.3 Market size and forecast, by End user

7.4.5.6 Indonesia

7.4.5.6.1 Market size and forecast, by Type

7.4.5.6.2 Market size and forecast, by Livestock

7.4.5.6.3 Market size and forecast, by End user

7.4.5.7 Thailand

7.4.5.7.1 Market size and forecast, by Type

7.4.5.7.2 Market size and forecast, by Livestock

7.4.5.7.3 Market size and forecast, by End user

7.4.5.8 Rest of Asia-Pacific

7.4.5.8.1 Market size and forecast, by Type

7.4.5.8.2 Market size and forecast, by Livestock

7.4.5.8.3 Market size and forecast, by End user

7.5 LAMEA

7.5.1 Key trends and opportunities

7.5.2 LAMEA Market size and forecast, by Type

7.5.3 LAMEA Market size and forecast, by Livestock

7.5.4 LAMEA Market size and forecast, by End user

7.5.5 LAMEA Market size and forecast, by country

7.5.5.1 Latin America

7.5.5.1.1 Market size and forecast, by Type

7.5.5.1.2 Market size and forecast, by Livestock

7.5.5.1.3 Market size and forecast, by End user

7.5.5.2 Middle East

7.5.5.2.1 Market size and forecast, by Type

7.5.5.2.2 Market size and forecast, by Livestock

7.5.5.2.3 Market size and forecast, by End user

7.5.5.3 Africa

7.5.5.3.1 Market size and forecast, by Type

7.5.5.3.2 Market size and forecast, by Livestock

7.5.5.3.3 Market size and forecast, by End user

8.1. Introduction

8.2. Top winning strategies

8.3. Product Mapping of Top 10 Player

8.4. Competitive Dashboard

8.5. Competitive Heatmap

8.6. Key developments

9.1 Elanco Animal Health Incorporated

9.1.1 Company overview

9.1.2 Company snapshot

9.1.3 Operating business segments

9.1.4 Product portfolio

9.1.5 Business performance

9.1.6 Key strategic moves and developments

9.2 BOEHRINGER INGELHEIM GMBH

9.2.1 Company overview

9.2.2 Company snapshot

9.2.3 Operating business segments

9.2.4 Product portfolio

9.2.5 Business performance

9.2.6 Key strategic moves and developments

9.3 Zoetis Inc

9.3.1 Company overview

9.3.2 Company snapshot

9.3.3 Operating business segments

9.3.4 Product portfolio

9.3.5 Business performance

9.3.6 Key strategic moves and developments

9.4  MERCK & CO., INC

9.4.1 Company overview

9.4.2 Company snapshot

9.4.3 Operating business segments

9.4.4 Product portfolio

9.4.5 Business performance

9.4.6 Key strategic moves and developments

9.5 VIRBAC

9.5.1 Company overview

9.5.2 Company snapshot

9.5.3 Operating business segments

9.5.4 Product portfolio

9.5.5 Business performance

9.5.6 Key strategic moves and developments

9.6 VETOQUINOL S.A.

9.6.1 Company overview

9.6.2 Company snapshot

9.6.3 Operating business segments

9.6.4 Product portfolio

9.6.5 Business performance

9.6.6 Key strategic moves and developments

9.7 PETIQ, LLC

9.7.1 Company overview

9.7.2 Company snapshot

9.7.3 Operating business segments

9.7.4 Product portfolio

9.7.5 Business performance

9.7.6 Key strategic moves and developments

9.8 sequent scientific limited

9.8.1 Company overview

9.8.2 Company snapshot

9.8.3 Operating business segments

9.8.4 Product portfolio

9.8.5 Business performance

9.8.6 Key strategic moves and developments

9.9 KRKA GROUP

9.9.1 Company overview

9.9.2 Company snapshot

9.9.3 Operating business segments

9.9.4 Product portfolio

9.9.5 Business performance

9.9.6 Key strategic moves and developments

9.10 ECO ANIMAL HEALTH GROUP PLC

9.10.1 Company overview

9.10.2 Company snapshot

9.10.3 Operating business segments

9.10.4 Product portfolio

9.10.5 Business performance

9.10.6 Key strategic moves and developments

9.11  CEVA SANTÉ ANIMALE

9.11.1 Company overview

9.11.2 Company snapshot

9.11.3 Operating business segments

9.11.4 Product portfolio

9.11.5 Business performance

9.11.6 Key strategic moves and developments

9.12 CHANELLE PHARMA

9.12.1 Company overview

9.12.2 Company snapshot

9.12.3 Operating business segments

9.12.4 Product portfolio

9.12.5 Business performance

9.12.6 Key strategic moves and developments

9.13  BIMEDA ANIMAL HEALTH

9.13.1 Company overview

9.13.2 Company snapshot

9.13.3 Operating business segments

9.13.4 Product portfolio

9.13.5 Business performance

9.13.6 Key strategic moves and developments

9.14 NORBROOK

9.14.1 Company overview

9.14.2 Company snapshot

9.14.3 Operating business segments

9.14.4 Product portfolio

9.14.5 Business performance

9.14.6 Key strategic moves and developments

9.15 KYORITSU SEIYAKU CORPORATION

9.15.1 Company overview

9.15.2 Company snapshot

9.15.3 Operating business segments

9.15.4 Product portfolio

9.15.5 Business performance

9.15.6 Key strategic moves and development

LIST OF TABLES

TABLE 1. GLOBAL LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)

TABLE 2. LIVESTOCK PARASITICIDES MARKET, FOR ECTOPARASITICIDES , BY REGION, 2021-2031 ($MILLION)

TABLE 3. LIVESTOCK PARASITICIDES MARKET FOR ECTOPARASITICIDES , BY COUNTRY, 2021-2031 ($MILLION)

TABLE 4. LIVESTOCK PARASITICIDES MARKET, FOR ENDOPARASITICIDES , BY REGION, 2021-2031 ($MILLION)

TABLE 5. LIVESTOCK PARASITICIDES MARKET FOR ENDOPARASITICIDES , BY COUNTRY, 2021-2031 ($MILLION)

TABLE 6. LIVESTOCK PARASITICIDES MARKET, FOR ENDECTOCIDES, BY REGION, 2021-2031 ($MILLION)

TABLE 7. LIVESTOCK PARASITICIDES MARKET FOR ENDECTOCIDES, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 8. GLOBAL LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)

TABLE 9. LIVESTOCK PARASITICIDES MARKET, FOR CATTLE, BY REGION, 2021-2031 ($MILLION)

TABLE 10. LIVESTOCK PARASITICIDES MARKET FOR CATTLE, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 11. LIVESTOCK PARASITICIDES MARKET, FOR PIGS, BY REGION, 2021-2031 ($MILLION)

TABLE 12. LIVESTOCK PARASITICIDES MARKET FOR PIGS, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 13. LIVESTOCK PARASITICIDES MARKET, FOR POULTRY, BY REGION, 2021-2031 ($MILLION)

TABLE 14. LIVESTOCK PARASITICIDES MARKET FOR POULTRY, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 15. LIVESTOCK PARASITICIDES MARKET, FOR SHEEP AND GOATS, BY REGION, 2021-2031 ($MILLION)

TABLE 16. LIVESTOCK PARASITICIDES MARKET FOR SHEEP AND GOATS, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 17. GLOBAL LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 18. LIVESTOCK PARASITICIDES MARKET, FOR VETERINARY CLINICS AND HOSPITALS, BY REGION, 2021-2031 ($MILLION)

TABLE 19. LIVESTOCK PARASITICIDES MARKET FOR VETERINARY CLINICS AND HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 20. LIVESTOCK PARASITICIDES MARKET, FOR ANIMAL FARMS, BY REGION, 2021-2031 ($MILLION)

TABLE 21. LIVESTOCK PARASITICIDES MARKET FOR ANIMAL FARMS, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 22. LIVESTOCK PARASITICIDES MARKET, BY REGION, 2021-2031 ($MILLION)

TABLE 23. NORTH AMERICA LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)

TABLE 24. NORTH AMERICA LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)

TABLE 25. NORTH AMERICA LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 26. NORTH AMERICA LIVESTOCK PARASITICIDES MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 27. U.S. LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)

TABLE 28. U.S. LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)

TABLE 29. U.S. LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 30. CANADA LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)

TABLE 31. CANADA LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)

TABLE 32. CANADA LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 33. MEXICO LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)

TABLE 34. MEXICO LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)

TABLE 35. MEXICO LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 36. EUROPE LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)

TABLE 37. EUROPE LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)

TABLE 38. EUROPE LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 39. EUROPE LIVESTOCK PARASITICIDES MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 40. UK LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)

TABLE 41. UK LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)

TABLE 42. UK LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 43. ITALY LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)

TABLE 44. ITALY LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)

TABLE 45. ITALY LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 46. GERMANY LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)

TABLE 47. GERMANY LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)

TABLE 48. GERMANY LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 49. FRANCE LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)

TABLE 50. FRANCE LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)

TABLE 51. FRANCE LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 52. SPAIN LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)

TABLE 53. SPAIN LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)

TABLE 54. SPAIN LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 55. THE NETHERLANDS LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)

TABLE 56. THE NETHERLANDS LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)

TABLE 57. THE NETHERLANDS LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 58. SWITZERLAND LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)

TABLE 59. SWITZERLAND LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)

TABLE 60. SWITZERLAND LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 61. REST OF EUROPE LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)

TABLE 62. REST OF EUROPE LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)

TABLE 63. REST OF EUROPE LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 64. ASIA-PACIFIC LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)

TABLE 65. ASIA-PACIFIC LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)

TABLE 66. ASIA-PACIFIC LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 67. ASIA-PACIFIC LIVESTOCK PARASITICIDES MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 68. CHINA LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)

TABLE 69. CHINA LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)

TABLE 70. CHINA LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 71. JAPAN LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)

TABLE 72. JAPAN LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)

TABLE 73. JAPAN LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 74. INDIA LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)

TABLE 75. INDIA LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)

TABLE 76. INDIA LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 77. SOUTH KOREA LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)

TABLE 78. SOUTH KOREA LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)

TABLE 79. SOUTH KOREA LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 80. AUSTRALIA LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)

TABLE 81. AUSTRALIA LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)

TABLE 82. AUSTRALIA LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 83. INDONESIA LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)

TABLE 84. INDONESIA LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)

TABLE 85. INDONESIA LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 86. THAILAND  LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)

TABLE 87. THAILAND  LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)

TABLE 88. THAILAND  LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 89. REST OF ASIA-PACIFIC LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)

TABLE 90. REST OF ASIA-PACIFIC LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)

TABLE 91. REST OF ASIA-PACIFIC LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 92. LAMEA LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)

TABLE 93. LAMEA LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)

TABLE 94. LAMEA LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 95. LAMEA LIVESTOCK PARASITICIDES MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 96. LATIN AMERICA LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)

TABLE 97. LATIN AMERICA LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)

TABLE 98. LATIN AMERICA LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 99. MIDDLE EAST LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)

TABLE 100. MIDDLE EAST LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)

TABLE 101. MIDDLE EAST LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 102. AFRICA LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)

TABLE 103. AFRICA LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)

TABLE 104. AFRICA LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 105.ELANCO ANIMAL HEALTH INCORPORATED: COMPANY SNAPSHOT

TABLE 106.ELANCO ANIMAL HEALTH INCORPORATED: OPERATING SEGMENTS

TABLE 107.ELANCO ANIMAL HEALTH INCORPORATED: PRODUCT PORTFOLIO

TABLE 108.ELANCO ANIMAL HEALTH INCORPORATED: NET SALES,

TABLE 109.ELANCO ANIMAL HEALTH INCORPORATED: KEY STRATERGIES

TABLE 110.BOEHRINGER INGELHEIM GMBH: COMPANY SNAPSHOT

TABLE 111.BOEHRINGER INGELHEIM GMBH: OPERATING SEGMENTS

TABLE 112.BOEHRINGER INGELHEIM GMBH: PRODUCT PORTFOLIO

TABLE 113.BOEHRINGER INGELHEIM GMBH: NET SALES,

TABLE 114.BOEHRINGER INGELHEIM GMBH: KEY STRATERGIES

TABLE 115.ZOETIS INC: COMPANY SNAPSHOT

TABLE 116.ZOETIS INC: OPERATING SEGMENTS

TABLE 117.ZOETIS INC: PRODUCT PORTFOLIO

TABLE 118.ZOETIS INC: NET SALES,

TABLE 119.ZOETIS INC: KEY STRATERGIES

TABLE 120. MERCK & CO., INC: COMPANY SNAPSHOT

TABLE 121. MERCK & CO., INC: OPERATING SEGMENTS

TABLE 122. MERCK & CO., INC: PRODUCT PORTFOLIO

TABLE 123. MERCK & CO., INC: NET SALES,

TABLE 124. MERCK & CO., INC: KEY STRATERGIES

TABLE 125.VIRBAC: COMPANY SNAPSHOT

TABLE 126.VIRBAC: OPERATING SEGMENTS

TABLE 127.VIRBAC: PRODUCT PORTFOLIO

TABLE 128.VIRBAC: NET SALES,

TABLE 129.VIRBAC: KEY STRATERGIES

TABLE 130.VETOQUINOL S.A.: COMPANY SNAPSHOT

TABLE 131.VETOQUINOL S.A.: OPERATING SEGMENTS

TABLE 132.VETOQUINOL S.A.: PRODUCT PORTFOLIO

TABLE 133.VETOQUINOL S.A.: NET SALES,

TABLE 134.VETOQUINOL S.A.: KEY STRATERGIES

TABLE 135.PETIQ, LLC: COMPANY SNAPSHOT

TABLE 136.PETIQ, LLC: OPERATING SEGMENTS

TABLE 137.PETIQ, LLC: PRODUCT PORTFOLIO

TABLE 138.PETIQ, LLC: NET SALES,

TABLE 139.PETIQ, LLC: KEY STRATERGIES

TABLE 140.SEQUENT SCIENTIFIC LIMITED: COMPANY SNAPSHOT

TABLE 141.SEQUENT SCIENTIFIC LIMITED: OPERATING SEGMENTS

TABLE 142.SEQUENT SCIENTIFIC LIMITED: PRODUCT PORTFOLIO

TABLE 143.SEQUENT SCIENTIFIC LIMITED: NET SALES,

TABLE 144.SEQUENT SCIENTIFIC LIMITED: KEY STRATERGIES

TABLE 145.KRKA GROUP: COMPANY SNAPSHOT

TABLE 146.KRKA GROUP: OPERATING SEGMENTS

TABLE 147.KRKA GROUP: PRODUCT PORTFOLIO

TABLE 148.KRKA GROUP: NET SALES,

TABLE 149.KRKA GROUP: KEY STRATERGIES

TABLE 150.ECO ANIMAL HEALTH GROUP PLC: COMPANY SNAPSHOT

TABLE 151.ECO ANIMAL HEALTH GROUP PLC: OPERATING SEGMENTS

TABLE 152.ECO ANIMAL HEALTH GROUP PLC: PRODUCT PORTFOLIO

TABLE 153.ECO ANIMAL HEALTH GROUP PLC: NET SALES,

TABLE 154.ECO ANIMAL HEALTH GROUP PLC: KEY STRATERGIES

TABLE 155. CEVA SANTÉ ANIMALE: COMPANY SNAPSHOT

TABLE 156. CEVA SANTÉ ANIMALE: OPERATING SEGMENTS

TABLE 157. CEVA SANTÉ ANIMALE: PRODUCT PORTFOLIO

TABLE 158. CEVA SANTÉ ANIMALE: NET SALES,

TABLE 159. CEVA SANTÉ ANIMALE: KEY STRATERGIES

TABLE 160.CHANELLE PHARMA: COMPANY SNAPSHOT

TABLE 161.CHANELLE PHARMA: OPERATING SEGMENTS

TABLE 162.CHANELLE PHARMA: PRODUCT PORTFOLIO

TABLE 163.CHANELLE PHARMA: NET SALES,

TABLE 164.CHANELLE PHARMA: KEY STRATERGIES

TABLE 165. BIMEDA ANIMAL HEALTH: COMPANY SNAPSHOT

TABLE 166. BIMEDA ANIMAL HEALTH: OPERATING SEGMENTS

TABLE 167. BIMEDA ANIMAL HEALTH: PRODUCT PORTFOLIO

TABLE 168. BIMEDA ANIMAL HEALTH: NET SALES,

TABLE 169. BIMEDA ANIMAL HEALTH: KEY STRATERGIES

TABLE 170.NORBROOK: COMPANY SNAPSHOT

TABLE 171.NORBROOK: OPERATING SEGMENTS

TABLE 172.NORBROOK: PRODUCT PORTFOLIO

TABLE 173.NORBROOK: NET SALES,

TABLE 174.NORBROOK: KEY STRATERGIES

TABLE 175.KYORITSU SEIYAKU CORPORATION: COMPANY SNAPSHOT

TABLE 176.KYORITSU SEIYAKU CORPORATION: OPERATING SEGMENTS

TABLE 177.KYORITSU SEIYAKU CORPORATION: PRODUCT PORTFOLIO

TABLE 178.KYORITSU SEIYAKU CORPORATION: NET SALES,

TABLE 179.KYORITSU SEIYAKU CORPORATION: KEY STRATERGIES LIST OF FIGURES

FIGURE 1.LIVESTOCK PARASITICIDES MARKET SEGMENTATION

FIGURE 2.LIVESTOCK PARASITICIDES MARKET,2021-2031

FIGURE 3.LIVESTOCK PARASITICIDES MARKET,2021-2031

FIGURE 4. TOP INVESTMENT POCKETS, BY REGION

FIGURE 5.PORTER FIVE-1

FIGURE 6.PORTER FIVE-2

FIGURE 7.PORTER FIVE-3

FIGURE 8.PORTER FIVE-4

FIGURE 9.PORTER FIVE-5

FIGURE 10.TOP PLAYER POSITIONING

FIGURE 11.LIVESTOCK PARASITICIDES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 12.LIVESTOCK PARASITICIDES MARKET,BY TYPE ,2021(%)

FIGURE 13.COMPARATIVE SHARE ANALYSIS OF ECTOPARASITICIDES  LIVESTOCK PARASITICIDES MARKET,2021-2031(%)

FIGURE 14.COMPARATIVE SHARE ANALYSIS OF ENDOPARASITICIDES  LIVESTOCK PARASITICIDES MARKET,2021-2031(%)

FIGURE 15.COMPARATIVE SHARE ANALYSIS OF ENDECTOCIDES LIVESTOCK PARASITICIDES MARKET,2021-2031(%)

FIGURE 16.LIVESTOCK PARASITICIDES MARKET,BY LIVESTOCK,2021(%)

FIGURE 17.COMPARATIVE SHARE ANALYSIS OF CATTLE LIVESTOCK PARASITICIDES MARKET,2021-2031(%)

FIGURE 18.COMPARATIVE SHARE ANALYSIS OF PIGS LIVESTOCK PARASITICIDES MARKET,2021-2031(%)

FIGURE 19.COMPARATIVE SHARE ANALYSIS OF POULTRY LIVESTOCK PARASITICIDES MARKET,2021-2031(%)

FIGURE 20.COMPARATIVE SHARE ANALYSIS OF SHEEP AND GOATS LIVESTOCK PARASITICIDES MARKET,2021-2031(%)

FIGURE 21.LIVESTOCK PARASITICIDES MARKET,BY END USER,2021(%)

FIGURE 22.COMPARATIVE SHARE ANALYSIS OF VETERINARY CLINICS AND HOSPITALS LIVESTOCK PARASITICIDES MARKET,2021-2031(%)

FIGURE 23.COMPARATIVE SHARE ANALYSIS OF ANIMAL FARMS LIVESTOCK PARASITICIDES MARKET,2021-2031(%)

FIGURE 24.LIVESTOCK PARASITICIDES MARKET BY REGION,2021

FIGURE 25.U.S. LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)

FIGURE 26.CANADA LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)

FIGURE 27.MEXICO LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)

FIGURE 28.UK LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)

FIGURE 29.ITALY LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)

FIGURE 30.GERMANY LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)

FIGURE 31.FRANCE LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)

FIGURE 32.SPAIN LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)

FIGURE 33.THE NETHERLANDS LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)

FIGURE 34.SWITZERLAND LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)

FIGURE 35.REST OF EUROPE LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)

FIGURE 36.CHINA LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)

FIGURE 37.JAPAN LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)

FIGURE 38.INDIA LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)

FIGURE 39.SOUTH KOREA LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)

FIGURE 40.AUSTRALIA LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)

FIGURE 41.INDONESIA LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)

FIGURE 42.THAILAND  LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)

FIGURE 43.REST OF ASIA-PACIFIC LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)

FIGURE 44.LATIN AMERICA LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)

FIGURE 45.MIDDLE EAST LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)

FIGURE 46.AFRICA LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)

FIGURE 47. TOP WINNING STRATEGIES, BY YEAR

FIGURE 48. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 49. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 50.PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 51.COMPETITIVE DASHBOARD

FIGURE 52.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS

FIGURE 53.ELANCO ANIMAL HEALTH INCORPORATED.: NET SALES ,($MILLION)

FIGURE 54.BOEHRINGER INGELHEIM GMBH.: NET SALES ,($MILLION)

FIGURE 55.ZOETIS INC.: NET SALES ,($MILLION)

FIGURE 56. MERCK & CO., INC.: NET SALES ,($MILLION)

FIGURE 57.VIRBAC.: NET SALES ,($MILLION)

FIGURE 58.VETOQUINOL S.A..: NET SALES ,($MILLION)

FIGURE 59.PETIQ, LLC.: NET SALES ,($MILLION)

FIGURE 60.SEQUENT SCIENTIFIC LIMITED.: NET SALES ,($MILLION)

FIGURE 61.KRKA GROUP.: NET SALES ,($MILLION)

FIGURE 62.ECO ANIMAL HEALTH GROUP PLC.: NET SALES ,($MILLION)

FIGURE 63. CEVA SANTÉ ANIMALE.: NET SALES ,($MILLION)

FIGURE 64.CHANELLE PHARMA.: NET SALES ,($MILLION)

FIGURE 65. BIMEDA ANIMAL HEALTH.: NET SALES ,($MILLION)

FIGURE 66.NORBROOK.: NET SALES ,($MILLION)

FIGURE 67.KYORITSU SEIYAKU CORPORATION.: NET SALES ,($MILLION